跳至主導覽 跳至搜尋 跳過主要內容

Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes

  • Maris Davis
  • , Michael Mellman
  • , Seth Friedman
  • , Chee Jen Chang
  • , Harry Shamoon*
  • *此作品的通信作者
  • Einstein Diabetes Research and Training Center

研究成果: 期刊稿件 › 文章 › 同儕審查

30 引文 斯高帕斯(Scopus)

摘要

purpose: Patients with intensively treated insulin-dependent diabetes mellitus (IDDM) exhibit more severe defects in counterregulatory hormone secretion and symptom recognition during hypoglycemia than do conventionally treated patients. In this prospective study in patients with preexisting defects in counterregulation, we examined the induction and reversibility of impaired symptomatic and adrenomedullary responses to hypoglycemia in 5 patients with IDDM (diabetes duration of 2 to 16 years; aged 19 to 36 years; 3 women, 2 men) who were receiving intensive therapy. methods: Counterregulatory responses were assessed by using a single-step (∼2.8 mmol/L plasma glucose) and multiple-step (from ∼5 mmol/L to 2.2 mmol/L plasma glucose) clamped hypoglycemia procedure. Patients were first studied after a stable period of conventional insulin therapy (glycosylated hemoglobin [HbA1c] 9.5 ± 1.2%), then after 3 to 5 months of intensive therapy (HbA1c 6.6 ± 0.2%), and a third time after resuming conventional therapy (HbA1c 8.7 ± 0.9%). results: Intensive therapy was associated with a 44% decline (P <0.01) in the average plasma epinephrine increase during hypoglycemia, and the plasma glucose level required to stimulate epinephrine secretion fell from 3.7 ± 0.2 to 3.0 ± 0.1 mmol/L (P <0.01). The threshold, but not the magnitude, of the plasma norepinephrine response was similarly altered. Hypoglycemic symptoms also decreased in intensity (by 67%, P <0.01), and the glucose level required for symptom activation fell from 3.4 ± 0.3 to 2.7 ± 0.2 mmol/L, P <0.01). When conventional therapy was resumed, the abnormalities in the epinephrine response due to intensive therapy were almost completely reversed. However, the reduction in symptoms and the altered thresholds for plasma norepinephrine were not reversed. conclusions: There is dissociation between the treatment-associated defects in hypoglycemia counterregulation in IDDM, and an increase in average glycemia produced by a return to conventional insulin therapy is not sufficient to reverse hypoglycemia unawareness worsened by intensive therapy.

原文英語
頁(從 - 到)535-542
頁數8
期刊American Journal of Medicine
卷97
發行號6
DOIs
出版品狀態已出版 - 12 1994
對外發佈是

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes」主題。共同形成了獨特的指紋。

引用此